These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8196908)

  • 1. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
    Brufman G; Isacson R; Haim N; Gez E; Sulkes A
    Oncology; 1994; 51(3):258-61. PubMed ID: 8196908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
    Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
    J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megestrol acetate in advanced breast carcinoma.
    Espie M
    Oncology; 1994 Oct; 51 Suppl 1():8-12. PubMed ID: 7970508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megestrol acetate: first-line therapy for advanced breast cancer.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
    Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimide.
    Horton J; Knuiman M; Keller AM; Vogel H; Gale KE; Hahn RG; Rosenbluth RJ; Tormey DC
    Cancer; 1987 Nov; 60(9):2137-40. PubMed ID: 3440224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial.
    Russell CA; Green SJ; O'Sullivan J; Hynes HE; Budd GT; Congdon JE; Martino S; Osborne CK
    J Clin Oncol; 1997 Jul; 15(7):2494-501. PubMed ID: 9215817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Which hormone therapy should be used in advanced breast carcinoma in males?].
    Lönning PE; Wiedemann G; Kvinnsland S; Lundgren S
    Dtsch Med Wochenschr; 1988 Sep; 113(35):1358-61. PubMed ID: 2970379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
    Buzdar A; Jonat W; Howell A; Jones SE; Blomqvist C; Vogel CL; Eiermann W; Wolter JM; Azab M; Webster A; Plourde PV
    J Clin Oncol; 1996 Jul; 14(7):2000-11. PubMed ID: 8683230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
    Muss HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Stuart JJ; Richards F
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):55-61. PubMed ID: 3883503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
    Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A
    Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megestrol acetate versus aminoglutethimide for metastatic breast cancer.
    Lundgren S; Gundersen S; Klepp R; Lønning PE; Lund E; Kvinnsland S
    Breast Cancer Res Treat; 1989 Nov; 14(2):201-6. PubMed ID: 2690972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetate.
    Crawford DJ; George WD; Smith DC; Stewart M; Paul J; Leake RE
    Oncology; 1994 Oct; 51 Suppl 1():13-8. PubMed ID: 7970503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
    Morgan LR
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
    Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen.
    Ross MB; Buzdar AU; Blumenschein GR
    Cancer; 1982 Feb; 49(3):413-7. PubMed ID: 6174195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
    Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
    Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of megestrol acetate for the treatment of advanced breast cancer.
    Sedlacek SM
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):3-13. PubMed ID: 3285483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megestrol acetate: a new role in the treatment of metastatic breast cancer.
    Allegra JC
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):45-7. PubMed ID: 3589707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.
    Ahlgren JD; Ellison NM; Gottlieb RJ; Laluna F; Lokich JJ; Sinclair PR; Ueno W; Wampler GL; Yeung KY; Alt D
    J Clin Oncol; 1993 Oct; 11(10):1957-68. PubMed ID: 7691999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.